China has the world’s third-largest number of cat and dog owners. Keeping pets flea-free is a priority. Acquisitive Chinese investment group Fosun International is reportedly on the lookout for ways to capitalise on the trend by considering a bid for the animal health business of German chemicals company Bayer, known for flea-and-tick fighter Advantage. The unit would be an appealing asset — but it could prove costly for Fosun.
中國貓狗主人數量居全球第三。讓寵物不生跳蚤是頭等大事。據報道，收購意識較強的中國投資集團復星國際(Fosun International)正考慮通過競購德國化工企業拜耳(Bayer)的動物保健業務從這一趨勢中獲利——拜耳的寵物驅蟲劑蚤安(Advantage)非常出名。該業務將是一項頗具吸引力的資產——但對復星而言，獲取這項資產的代價可能不菲。
您已閱讀22%（603字），剩餘78%（2172字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。